How The Pulmonx (LUNG) Investment Narrative Is Resetting Around A Lower Target And Execution Risk [Yahoo! Finance]
Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026
How The Pulmonx (LUNG) Investment Story Is Shifting After Q4 And New Guidance [Yahoo! Finance]
How The Pulmonx (LUNG) Narrative Is Resetting Around Execution Risks And Fair Value Assumptions [Yahoo! Finance]
Pulmonx (LUNG) had its price target lowered by Canaccord Genuity Group Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.